Association between serum zinc consentrations and renal anemia in patients with hemodialysis

Association between serum zinc consentrations and renal anemia in patients with hemodialysis - Association of zinc and anemia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017032

Enrollment

Registered

2015-04-03

Start date

2013-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal anemia

Interventions

Oral zinc supplementation Control

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) age more than 20 years or less than 85 years, (2) on hemodialysis for at least 6 months, and (3) zinc deficiency defined as a serum zinc level < 65 micro g/dl

Exclusion criteria

Exclusion criteria: (1) age of < 20 years or > 85 years; (2) recent infectious disease, cancer, or drug/alcohol abuse; (3) treatment with steroids or immunosuppressants; (4) currently hospitalized; (5) previous history of blood transfusion for at least 6 months before the study; or (6) recent hospitalization or unwillingness to participate in the study.

Design outcomes

Primary

Measure	Time frame
hemoglobin concentration, Dose of erythropoiesis stimulating agent(ESA), ESA responsiveness index	—

Countries

Japan

Contacts

Public ContactMasanori Abe

Nihon University School of Medicine Nephrology, Hypertension and Endocrinology

mabe@med.nihon-u.ac.jp03-3972-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026